0059 GMT - Ansell's sales volumes could be at risk from lower demand amid slower economic growth, Morgan Stanley analyst David L. Bailey writes in a note. While the personal-protective equipment maker has said it will offset the impact of tariffs through higher pricing, Bailey no longer expects revenue to grow at Ansell's industrial business in fiscal 2026 or fiscal 2027. He forecasts a 1% decline in industrial revenue in both years, having previously expected 4% growth in each. The healthcare unit is less exposed, but Bailey trims his overall EPS forecasts for fiscal 2026 and 2027 by 9% and 11%, respectively. MS cuts its target price 10% to A$33.40 and stays equal-weight on the stock. Shares are down 0.9% at A$29.435. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
April 13, 2025 20:59 ET (00:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.